• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION(RIDGEFIELD) SYNVISC; MOZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION(RIDGEFIELD) SYNVISC; MOZ Back to Search Results
Lot Number ARSP005C
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arthritis (1723); Neuropathy (1983); Ambulation Difficulties (2544)
Event Type  Injury  
Event Description
Issues with her sciatic nerve being pinched [pinched nerve].Having less difficulty however does walk with a cane and is careful [walking difficulty].Get some tests done for arthritis/ has some in her knees as well as her back [arthritis].Case narrative: initial information received on 15-may-2023 regarding a solicited valid serious case received from a patient, in the scope of post-marketing sponsored study "spon_i_synvisc".Patient id: unknown; country: canada.Study title: patient support program involving synvisc.This case involves an elderly female patient who was having less difficulty however does walk with a cane, issues with her sciatic nerve being pinched, and was careful and get some tests done for arthritis/ had some in her knees as well as her back with the use of medical device hylan g-f 20, sodium hyaluronate (synvisc).The patient's past medical history, medical treatment(s), concomitant medication(s) and family history were not provided.It was unknown if the patient had any concomitant disease or risk factor.On (b)(6)2021, the patient received 1st hylan g-f 20, sodium hyaluronate injection in her left knee at a dose of 2ml 3x intra-articular (lot - arsp005c, expiry date, indication and strength).On an unknown date after unknown latency, the patient had an issues with her sciatic nerve being pinched (nerve compression).She was having less difficulty however did walk with a cane and was careful (gait disturbance), which was helping her.As on her physician request the patient get some tests done for arthritis and would see a specialist regarding her results for arthritis.She had some in her knees as well as her back (arthritis).Action taken: no action taken for all events.Corrective treatment: walk with a cane for all the events.At time of reporting, the outcome was unknown for the event having less difficulty however does walk with a cane and is careful and not recovered for rest of the events.Reporter causality: not reported for all events.Company causality: not reportable for all events.Seriousness criteria: disability for all the events.A product technical complaint (ptc) was initiated, and the results were pending for the same.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC
Type of Device
MOZ
Manufacturer (Section G)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer Contact
heather schiappacasse
55 corporate drive, ms 55b-220
a
bridgewater 08807
MDR Report Key17017199
MDR Text Key316196482
Report Number2246315-2023-00052
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 05/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Lot NumberARSP005C
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/29/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient SexFemale
-
-